Valuation UCB Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 02:03:17 2026-07-23 EDT			5-day change	1st Jan Change
243.60 ^EUR	+0.16%		+5.09%	+3.66%

07-14	Where would AI lead Pharma in the long run?
07-13	Antengene Receives $60 Million Milestone in UCB Licensing Deal	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,947	13,973	14,969	36,464	45,333	46,258	-	-
Change	-	-26.25%	7.12%	143.6%	24.32%	2.04%	-	-
Enterprise Value (EV) ¹	19,807	15,973	17,146	37,918	45,326	46,016	43,935	41,400
Change	-	-19.36%	7.34%	121.15%	19.54%	1.52%	-4.52%	-5.77%
P/E	17.9x	33.4x	44.8x	34.3x	29.1x	26x	20.7x	16.6x
PBR	2.32x	1.58x	1.67x	3.64x	4.18x	3.94x	3.38x	2.78x
PEG	-	-0.6x	-2.2x	0x	0.6x	1.9x	0.8x	0.7x
Capitalization / Revenue	3.28x	2.53x	2.85x	5.93x	5.86x	5.41x	4.8x	4.3x
EV / Revenue	3.43x	2.9x	3.26x	6.16x	5.86x	5.39x	4.56x	3.85x
EV / EBITDA	12.1x	12.7x	12.7x	25.7x	17.2x	15.8x	12.2x	9.68x
EV / EBIT	15x	23.7x	26.1x	45.4x	22.6x	19.6x	14.9x	11.3x
EV / FCF	15.6x	18.4x	38.5x	41.2x	24.6x	23.3x	16.9x	13.2x
FCF Yield	6.42%	5.43%	2.6%	2.43%	4.06%	4.29%	5.93%	7.55%
Dividend per Share ²	1.3	1.33	1.36	1.39	1.45	1.465	1.505	1.538
Rate of return	1.3%	1.81%	1.72%	0.72%	0.61%	0.6%	0.62%	0.63%
EPS ²	5.6	2.2	1.76	5.61	8.2	9.334	11.76	14.66
Distribution rate	23.2%	60.5%	77.3%	24.8%	17.7%	15.7%	12.8%	10.5%
Net sales ¹	5,777	5,517	5,252	6,152	7,741	8,543	9,644	10,756
EBITDA ¹	1,641	1,260	1,349	1,476	2,636	2,907	3,599	4,278
EBIT ¹	1,318	675	657	836	2,009	2,345	2,957	3,666
Net income ¹	1,058	418	343	1,065	1,558	1,770	2,277	2,835
Net Debt ¹	860	2,000	2,177	1,454	-7	-242.2	-2,323	-4,858
Reference price ²	100.35	73.56	78.90	192.20	238.60	243.00	243.00	243.00
Nbr of stocks (in thousands)	188,812	189,959	189,721	189,720	189,996	190,361	-	-
Announcement Date	2/24/22	2/22/23	2/28/24	2/27/25	2/24/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	17.15x	3.68x	9.49x	0.6%	66.25B
SAMSUNG BIOLOGICS CO.,LTD.	33.98x	11.48x	21.98x	-.--%	43.01B
CSL LIMITED	-44.33x	3.15x	9.3x	3.45%	39.52B
BIOGEN INC.	24.04x	3.43x	11.65x	-.--%	29.19B
INCYTE CORPORATION	55.87x	3.21x	26.87x	-.--%	23.13B
MODERNA, INC.	-6.71x	9.37x	-5.77x	-.--%	23.04B
INNOVENT BIOLOGICS, INC.	66.64x	6.57x	45.21x	-.--%	20.48B
SWEDISH ORPHAN BIOVITRUM AB	24.35x	5.21x	13.64x	-.--%	16.6B
BRIDGEBIO PHARMA, INC.	-37.32x	17.71x	-48.48x	-.--%	16.2B
Average	14.85x	7.09x	9.32x	0.45%	30.83B
Weighted average by Cap.	13.88x	6.34x	11.31x	0.64%